Purigen Biosystems Raises $26.4 Million Series B Financing to Accelerate Commercialization of Automated Sample Preparation Platform

News
2019
2018
Archive

May 17, 2019

Homology Medicines Announces FDA Fast Track Designation for HMI-102 Gene Therapy Development Candidate for Adults with PKU
May 17, 2019

Pear Therapeutics Initiates Feasibility Study to Treat Depressive Symptoms in People with Multiple Sclerosis
May 17, 2019

IDEAYA Receives Authorization to Proceed with Phase 1/2 Tissue-Type Agnostic Basket Trial to Treat Patients with Tumors Harboring GNAQ/11 Mutations and PKC Fusions
May 17, 2019

Audentes Therapeutics Announces Launch of New State-of-the-Art Internal cGMP Plasmid Manufacturing Facility
May 17, 2019

Aprea Therapeutics Receives FDA Fast Track Designation and Orphan Drug Designation for APR-246 for the Treatment of Myelodysplastic Syndromes (MDS)
April 15, 2019

Cidara Selects First Clinical Development Candidate From Its Cloudbreak Influenza (Antiviral) Program
April 11, 2019

NodThera Highlights Significant Progress with Advancement of Lead Development Candidate and Key Additions to Board
April 8, 2019

Audentes Therapeutics Announces Expansion of AAV Technology Platform and Pipeline with New Development Programs for Duchenne Muscular Dystrophy and Mytonic Dystrophy
April 4, 2019

Homology Medicines Presents Preclinical Data From PKU Gene Therapy Program Demonstrating Restored Metabolic Pathway And Increased Neurotransmitter Production
April 4, 2019

Homology Medicines Announces FDA Clearance of Investigational New Drug Application for HMI-102 Gene Therapy Candidate for PKU